INR 44.02
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 21.91 Billion INR | 0.08% |
2022 | 21.89 Billion INR | -8.43% |
2021 | 23.9 Billion INR | 0.11% |
2020 | 23.88 Billion INR | -9.31% |
2019 | 26.33 Billion INR | -2.65% |
2018 | 27.04 Billion INR | -0.69% |
2017 | 27.23 Billion INR | 5.54% |
2016 | 25.8 Billion INR | 0.96% |
2015 | 25.56 Billion INR | 5.21% |
2014 | 24.29 Billion INR | 1.49% |
2013 | 23.94 Billion INR | 5.28% |
2012 | 22.74 Billion INR | 7.22% |
2011 | 21.2 Billion INR | 17.01% |
2010 | 18.12 Billion INR | 22.43% |
2009 | 14.8 Billion INR | 15.16% |
2008 | 12.85 Billion INR | 35.54% |
2007 | 9.48 Billion INR | 22.06% |
2006 | 7.77 Billion INR | 69.91% |
2005 | 4.57 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 21.91 Billion INR | 0.08% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 21.91 Billion INR | 0.0% |
2023 Q2 | 21.42 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 21.89 Billion INR | -8.43% |
2022 Q2 | 22.88 Billion INR | 0.0% |
2022 Q4 | 21.89 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 23.9 Billion INR | 0.11% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 23.9 Billion INR | 0.0% |
2021 Q2 | 23.68 Billion INR | 0.0% |
2020 Q2 | 25.34 Billion INR | 0.0% |
2020 FY | 23.88 Billion INR | -9.31% |
2020 Q4 | 23.88 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 26.33 Billion INR | -2.65% |
2019 Q1 | - INR | -100.0% |
2019 Q4 | 26.33 Billion INR | 0.0% |
2019 Q2 | 27.05 Billion INR | 0.0% |
2018 FY | 27.04 Billion INR | -0.69% |
2018 Q4 | 27.04 Billion INR | 0.0% |
2017 FY | 27.23 Billion INR | 5.54% |
2016 FY | 25.8 Billion INR | 0.96% |
2015 FY | 25.56 Billion INR | 5.21% |
2014 FY | 24.29 Billion INR | 1.49% |
2013 FY | 23.94 Billion INR | 5.28% |
2012 FY | 22.74 Billion INR | 7.22% |
2011 FY | 21.2 Billion INR | 17.01% |
2010 FY | 18.12 Billion INR | 22.43% |
2009 FY | 14.8 Billion INR | 15.16% |
2008 FY | 12.85 Billion INR | 35.54% |
2007 FY | 9.48 Billion INR | 22.06% |
2006 FY | 7.77 Billion INR | 69.91% |
2005 FY | 4.57 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ajanta Pharma Limited | 46.38 Billion INR | 52.763% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -497.228% |
Sigachi Industries Limited | 6.94 Billion INR | -215.643% |
Bal Pharma Limited | 3.2 Billion INR | -583.874% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | -88.056% |
Medico Remedies Limited | 961.95 Million INR | -2177.717% |
Lasa Supergenerics Limited | 1.5 Billion INR | -1352.293% |
Venus Remedies Limited | 6.26 Billion INR | -249.546% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -325.415% |
Alpa Laboratories Limited | 1.82 Billion INR | -1099.779% |
Shilpa Medicare Limited | 30.93 Billion INR | 29.165% |
Aarti Drugs Limited | 24.32 Billion INR | 9.921% |
Lupin Limited | 239.97 Billion INR | 90.87% |
Aurobindo Pharma Limited | 450.71 Billion INR | 95.139% |
Zydus Lifesciences Limited | 292.8 Billion INR | 92.517% |
Windlas Biotech Limited | 6.26 Billion INR | -249.894% |
Suven Life Sciences Limited | 2.84 Billion INR | -669.054% |
Eris Lifesciences Limited | 70.48 Billion INR | 68.916% |
Valiant Laboratories Limited | 3.42 Billion INR | -539.375% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 45.143% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 6.802% |
Ipca Laboratories Limited | 111.01 Billion INR | 80.263% |
Bliss GVS Pharma Limited | 12.13 Billion INR | -80.502% |
Achyut Healthcare Limited | 309.52 Million INR | -6978.839% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.436% |
Bajaj HealthCare Limited | 7.65 Billion INR | -186.365% |
RPG Life Sciences Limited | 5.12 Billion INR | -327.215% |
Mankind Pharma Limited | 119.63 Billion INR | 81.685% |
Laurus Labs Limited | 83.87 Billion INR | 73.876% |
Piramal Pharma Limited | 153.11 Billion INR | 85.69% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -441.451% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 85.452% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 66.007% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 84.74% |
Unichem Laboratories Limited | 31.69 Billion INR | 30.867% |
Sequent Scientific Limited | 15.4 Billion INR | -42.241% |
Novartis India Limited | 9.24 Billion INR | -136.889% |
Wanbury Limited | 3.43 Billion INR | -537.875% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 2.796% |
Wockhardt Limited | 76.49 Billion INR | 71.355% |
Themis Medicare Limited | 5.66 Billion INR | -286.828% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -909.341% |
Jubilant Pharmova Limited | 115.48 Billion INR | 81.027% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 23.132% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 94.346% |
Divi's Laboratories Limited | 154.7 Billion INR | 85.837% |
NATCO Pharma Limited | 69.06 Billion INR | 68.275% |
Gufic Biosciences Limited | 10.92 Billion INR | -100.547% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 2.377% |
Ind-Swift Limited | 6.54 Billion INR | -234.783% |
Procter & Gamble Health Limited | 7.94 Billion INR | -175.827% |
FDC Limited | 24.68 Billion INR | 11.225% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1129.724% |
Granules India Limited | 55.2 Billion INR | 60.314% |
Medicamen Biotech Limited | 2.94 Billion INR | -643.935% |
Alkem Laboratories Limited | 155.74 Billion INR | 85.932% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | -103.247% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -4553.634% |
Brooks Laboratories Limited | 904.45 Million INR | -2322.518% |
Megasoft Limited | 3.65 Billion INR | -498.813% |
ZIM Laboratories Limited | 4.46 Billion INR | -390.364% |
Strides Pharma Science Limited | 58.39 Billion INR | 62.48% |
Neuland Laboratories Limited | 18.32 Billion INR | -19.563% |
Morepen Laboratories Limited | 12.93 Billion INR | -69.428% |
Hikal Limited | 24.87 Billion INR | 11.905% |
Indoco Remedies Limited | 21.44 Billion INR | -2.16% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 15.144% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -812.706% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -557.138% |
Hester Biosciences Limited | 6.62 Billion INR | -230.802% |